Research in nanotechnology is advancing targeted drug delivery systems that engineer nanoparticles to deliver drugs directly to specific cells or tissues. This approach enhances treatment efficacy and reduces side effects, particularly in diseases like cancer, allowing for smaller dosages and lower toxicity. Such advancements foster collaboration among biotech firms, healthcare providers, and research institutions, exemplified by companies like DoxiChem, which specialize in these systems.
Nanosys, a California-based leader in nanotechnology, specializes in quantum dots, significantly improving display technologies in televisions and smartphones. The company's proprietary technology enhances color accuracy and energy efficiency, meeting consumer demands for vibrant visuals. With a robust portfolio of patents, Nanosys is recognized as a pioneer in the field, underscoring its innovative contributions to nanotechnology.